2009
DOI: 10.1002/ppul.21111
|View full text |Cite
|
Sign up to set email alerts
|

Early elevations in B‐type natriuretic peptide levels are associated with poor clinical outcomes in pediatric acute lung injury

Abstract: Summary Objectives To determine B-type natriuretic peptide (BNP) levels in infants and children with acute lung injury (ALI), and to investigate associations between BNP levels and clinical outcome. Design Prospective observational study. Subjects After informed consent, plasma was collected from 48 pediatric patients on day 1 of ALI. Methodology Plasma BNP levels were measured by immunoassay on day 1 of ALI in 48 pediatric patients. Associations between BNP levels and outcome were determined. Results… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
9
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(12 citation statements)
references
References 44 publications
2
9
1
Order By: Relevance
“…There is conflicting data in adult ARDS about the utility of BNP as a marker of RV dysfunction and in predicting mortality (3336). Contrary to the only report of BNP levels in children with acute lung injury (37), we found that BNP concentration within the first 24 hours of PARDS diagnosis was not associated with patient outcomes and correlated best with LV FS. Despite its wide clinical use, BNP may not accurately reflect RV dysfunction in the setting of acute non-cardiac organ damage and inflammation such as in PARDS.…”
Section: Discussioncontrasting
confidence: 99%
“…There is conflicting data in adult ARDS about the utility of BNP as a marker of RV dysfunction and in predicting mortality (3336). Contrary to the only report of BNP levels in children with acute lung injury (37), we found that BNP concentration within the first 24 hours of PARDS diagnosis was not associated with patient outcomes and correlated best with LV FS. Despite its wide clinical use, BNP may not accurately reflect RV dysfunction in the setting of acute non-cardiac organ damage and inflammation such as in PARDS.…”
Section: Discussioncontrasting
confidence: 99%
“…Studies in adults have found that BNP can help discriminate ARDS from cardiogenic pulmonary edema, and higher BNP levels are associated with mortality ( 161 163 ). Similarly, in a cohort of children with ALI, elevated BNP levels early in the disease course were associated with worse oxygenation, fewer VFDs, increased need for inotropes, and were significantly elevated among non-survivors ( 52 ). These findings suggest BNP as a possible marker of the altered cardiopulmonary interactions that can occur in the setting of ALI in children.…”
Section: Biomarker Subgroupsmentioning
confidence: 95%
“…The lower mortality rate of PARDS (relative to adults), which appears to be decreasing over time (39,42), makes the selection of clinically relevant outcomes challenging for biomarker studies. Flori et al have demonstrated the prognostic utility of brain-type natriuretic peptide (27), plasminogen activator inhibitor-1 (30), and soluble intracellular adhesion molecule-1 [sICAM-1, (14)]. Others have validated the association between increased sICAM-1 and nonsurvival in PARDS (3,29).…”
Section: Discussionmentioning
confidence: 99%